Implementing a Survivorship Care Plan for Patients With Breast Cancer
- 10 February 2008
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 26 (5) , 759-767
- https://doi.org/10.1200/jco.2007.14.2851
Abstract
Breast cancer survivors account for 23% of the more than 10 million cancer survivors in the United States today. The treatments for breast cancer are complex and extend over a long period of time. The post-treatment period is characterized by gradual recovery from many adverse effects from treatment; however, many symptoms and problems persist as late effects (eg, infertility, menopausal symptoms, fatigue), and there may be less frequent long-term effects (eg, second cancers, lymphedema, osteoporosis). There is increasing recognition of the need to summarize the patient's course of treatment into a formal document, called the cancer treatment summary, that also includes recommendations for subsequent cancer surveillance, management of late effects, and strategies for health promotion. This article provides guidance on how oncologists can implement a cancer treatment summary and survivorship care plan for breast cancer survivors, with examples and linkage to useful resources. Providing the breast cancer treatment summary and survivorship care plan is being recognized as a key component of coordination of care that will foster the delivery of high-quality cancer care.Keywords
This publication has 27 references indexed in Scilit:
- Follow-up of Patients with Early Breast CancerNew England Journal of Medicine, 2007
- Future Supply and Demand for Oncologists : Challenges to Assuring Access to Oncology ServicesJournal of Oncology Practice, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Monitoring the Physical Health of Cancer Survivors: A Survivorship-Focused Medical HistoryJournal of Clinical Oncology, 2006
- Failing to Plan Is Planning to Fail: Improving the Quality of Care With Survivorship Care PlansJournal of Clinical Oncology, 2006
- Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast CancerJournal of Clinical Oncology, 2006
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- Quality of Life at the End of Primary Treatment of Breast Cancer: First Results From the Moving Beyond Cancer Randomized TrialJNCI Journal of the National Cancer Institute, 2004
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000JNCI Journal of the National Cancer Institute, 2001